Clinical Trial Update: Effects of Aripiprazole in Overweight Patients Treated With Olanzapine for Schizophrenia or Schizoaffective Disorder [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the effects of adding aripiprazole to olanzapine in overweight patients with schizophrenia or schizoaffective disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• ARIPIPRAZOLE (Aripiprazole)
• olanzapine (olanzapine)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Body Weight Change, Schizophrenia | Phase 3 | Status: COMPLETED